O ONC

BeiGene Ltd

BIOTECHNOLOGY · HEALTHCARE

BeiGene, Ltd. (Ticker: ONC) is a pioneering global biotechnology company focused on transforming cancer treatment by developing innovative therapies that meet critical unmet medical needs in oncology. With a robust pipeline of proprietary compounds and strategic collaborations, BeiGene is well-posit...

$309.62

+0.29% (+$0.88)

Volume 243,722

52W High $385.22

52W Low $234.80

Market Cap $34.01B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

May 6, 2026 Beat

Actual: $1.96 vs. Consensus: $0.79

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q1 2026 May 6, 2026

1-Day: +1.17%

5-Day: -0.82%

Q1 2026 Apr 30, 2026

1-Day: -0.48%

5-Day: +0.75%

Q4 2025 Feb 26, 2026

1-Day: -1.67%

5-Day: -7.86%

Q3 2025 Nov 6, 2025

1-Day: -3.73%

5-Day: +3.40%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q1'26	$1.51B	+35.5%	89.0%	16.5%	$227.4M
Q4'25	$1.50B	+32.8%	90.5%	12.4%	$66.5M
Q3'25	$1.41B	+41.0%	86.1%	11.6%	$124.8M
Q2'25	$1.32B	+41.6%	87.5%	6.7%	$94.3M
Q1'25	$1.12B	+48.6%	85.2%	1.0%	$1.3M
Q4'24	$1.13B	+77.8%	85.8%	-7.0%	-$151.9M
Q3'24	$1.00B	+28.2%	83.0%	-12.0%	-$121.4M
Q2'24	$929.2M	+56.1%	85.1%	-11.5%	-$120.4M

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q1 2026	May 6, 2026	$0.79	$0.93	$1.96	--	Beat
Q1 2026	Apr 30, 2026	$0.79	$0.90	$1.96	--	Beat
Q4 2025	Feb 26, 2026	$1.53	$1.50	$0.58	-62.09%	Missed
Q3 2025	Nov 6, 2025	$0.80	$0.92	$2.65	--	Beat
Q2 2025	Aug 6, 2025	$0.21	$0.24	$0.91	--	Beat
Q1 2025	May 7, 2025	-$0.43	-$0.43	$0.01	--	Beat
Q4 2024	Feb 27, 2025	-$1.01	-$1.01	-$1.43	-41.58%	Missed
Q3 2024	Nov 12, 2024	-$1.04	-$1.04	-$0.09	+91.35%	Beat
Q2 2024	Aug 7, 2024	-$2.19	-$2.19	-$1.15	+47.49%	Beat
Q1 2024	May 8, 2024	-$2.92	-$2.92	-$2.41	+17.47%	Beat
Q4 2023	Mar 30, 2024	-$3.54	-$3.54	-$3.53	+0.28%	Met
Q4 2023	Feb 26, 2024	-$3.54	-$3.54	-$3.53	+0.28%	Met